CLONAZEPAM

Rubicon Research's clonazepam NDA 216988, supplement 005, was added to FDA records.

Rubicon Research received FDA approval for clonazepam (NDA 216988, supplement 001).

Rubicon Research added clonazepam (CLONAZEPAM) NDA 216988 supplemental application 004 to the FDA drug product database.

Rubicon Research added a new product record (NDA 216988, supplemental application 002) for Clonazepam to Drugs@FDA.

Rubicon Research received FDA approval for clonazepam (Application 216988, Supplement 003).